329 related articles for article (PubMed ID: 38274225)
1. Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma.
Li X; Meng F; Wang H; Sun L; Chang S; Li G; Chen F
Front Endocrinol (Lausanne); 2023; 14():1319969. PubMed ID: 38274225
[TBL] [Abstract][Full Text] [Related]
2. New perspectives on ferroptosis and its role in hepatocellular carcinoma.
Cong T; Luo Y; Fu Y; Liu Y; Li Y; Li X
Chin Med J (Engl); 2022 Sep; 135(18):2157-2166. PubMed ID: 36525603
[TBL] [Abstract][Full Text] [Related]
3. The mechanism and progress of ferroptosis in pancreatic cancer.
Bao ZH; Hou XB; Li HL; Mao YF; Wang WR
Acta Histochem; 2022 Aug; 124(6):151919. PubMed ID: 35772355
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation.
Peleman C; Francque S; Berghe TV
EBioMedicine; 2024 Apr; 102():105088. PubMed ID: 38537604
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.
Ajoolabady A; Tang D; Kroemer G; Ren J
Br J Cancer; 2023 Jan; 128(2):190-205. PubMed ID: 36229582
[TBL] [Abstract][Full Text] [Related]
6. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.
Li L; Wang X; Xu H; Liu X; Xu K
Front Mol Biosci; 2022; 9():947208. PubMed ID: 36052168
[TBL] [Abstract][Full Text] [Related]
7. Targeting ferroptosis in hepatocellular carcinoma.
Mo Y; Zou Z; Chen E
Hepatol Int; 2024 Feb; 18(1):32-49. PubMed ID: 37880567
[TBL] [Abstract][Full Text] [Related]
8. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
9. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
10. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma.
Wang Z; Zhou C; Zhang Y; Tian X; Wang H; Wu J; Jiang S
Biomed Pharmacother; 2024 Jan; 170():116074. PubMed ID: 38147732
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis: a new promising target for hepatocellular carcinoma therapy.
Xu Q; Ren L; Ren N; Yang Y; Pan J; Zheng Y; Wang G
Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38051404
[TBL] [Abstract][Full Text] [Related]
13. The multifaceted role of ferroptosis in liver disease.
Chen J; Li X; Ge C; Min J; Wang F
Cell Death Differ; 2022 Mar; 29(3):467-480. PubMed ID: 35075250
[TBL] [Abstract][Full Text] [Related]
14. Role of ferroptosis in hepatocellular carcinoma.
Nie J; Lin B; Zhou M; Wu L; Zheng T
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
Lu Y; Chan YT; Tan HY; Zhang C; Guo W; Xu Y; Sharma R; Chen ZS; Zheng YC; Wang N; Feng Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):3. PubMed ID: 34980204
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis regulates key signaling pathways in gastrointestinal tumors: Underlying mechanisms and therapeutic strategies.
Rabitha R; Shivani S; Showket Y; Sudhandiran G
World J Gastroenterol; 2023 Apr; 29(16):2433-2451. PubMed ID: 37179581
[TBL] [Abstract][Full Text] [Related]
18. Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells.
Shang Y; Luo M; Yao F; Wang S; Yuan Z; Yang Y
Cell Signal; 2020 Aug; 72():109633. PubMed ID: 32283255
[TBL] [Abstract][Full Text] [Related]
19. Molecular Targets of Ferroptosis in Hepatocellular Carcinoma.
Liao H; Shi J; Wen K; Lin J; Liu Q; Shi B; Yan Y; Xiao Z
J Hepatocell Carcinoma; 2021; 8():985-996. PubMed ID: 34466409
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
